TR
İhbar gönder

Researchers Focus on the Nerve-Muscle Junction in Age-Related Weakness

A study in the Journal of Clinical Investigation links age-related muscle weakness with impaired signaling at the neuromuscular junction. The human comparison was small: 10 older adults with weakness were compared with eight younger or middle-aged controls. In aged rodents, inhibiting the ClC-1 channel improved muscle function. The animal result does not show that this approach is an effective treatment for people. ☼ The human study compared 10 older adults with weakness and eight controls. · ☼ Researchers reported impaired neuromuscular transmission associated with muscle strength. · ☼ ClC-1 inhibition improved function in aged rodents. · ☼ The animal result is not evidence of a human therapy; clinical studies are…

ILLUSTRATIVE
AGING · MUSCLE FUNCTIONNEUROMUSCULAR SIGNALA small human cohort and follow-up animal experimentsHUMAN COHORT10 + 8Older weak + controlsParticipant countSmall comparisonMEASUREMENT250%Higher mean jitterReported in older groupGroup findingANIMAL STUDYRODENTSClC-1 inhibitionImproved muscle functionNot a human treatmentSOURCE: JOURNAL OF CLINICAL INVESTIGATION, 2026 · DOI: 10.1172/JCI190646

What happens at the neuromuscular junction

A study in the Journal of Clinical Investigation suggests that impaired communication between nerves and muscles may contribute to age-related weakness. Muscle contraction depends on electrical signals traveling from motor nerves to muscle fibers, and the researchers found more frequent transmission failures in older adults with weakness.

The human comparison was small: 10 older people reporting physical limitation were compared with eight younger or middle-aged controls. The researchers reported that measures of transmission impairment were associated with muscle strength. The sample is too limited to represent older adults generally.

What the animal experiments showed

The team observed reduced density of the NaV1.4 sodium channel at the neuromuscular junction in aged human and rodent muscle tissue. In aged rodents, partial inhibition of the ClC-1 chloride channel improved muscle excitability, nerve-to-muscle transmission and contractile performance.

Those intervention results were obtained in animals. The study does not show that ClC-1 inhibitors treat sarcopenia or weakness in older people. Further work would be needed to establish whether the mechanism can be targeted safely and effectively in humans.

Sources

VERIFICATION STATUSLAST UPDATED 22:19
VERIFIED

Study published in the Journal of Clinical Investigation (2026), DOI 10.1172/JCI190646; human comparison group sizes (10 weak older adults vs 8 controls) and the ClC-1 rodent finding are stated in the study.

UNCERTAIN

The infographic's ‘250% higher mean jitter’ figure is not spelled out in the article body; the human sample is too small to generalize to older adults broadly.

MISSING

Whether ClC-1 inhibition is safe or effective in human patients has not been tested; response from the contacted researchers/journal not yet received.

Bu haber yapay zeka yardımıyla derlendi, yayın öncesi İbrahim Haskoloğlu tarafından kontrol edildi. Adı geçen kuruma yazılı soru gönderildi; yanıt geldiğinde haber güncellenir.

\n